A new Delaware bill is drawing fierce criticism from social conservatives and child-welfare advocates who argue it would legalize the paid transfer of a mother’s own biological child under the banner of surrogacy. Senate Bill 250, introduced March 5, would adopt major portions of the Uniform Parentage Act and expand Delaware law to recognize both gestational and “genetic” carrier agreements. In practical terms, that means a woman could agree to conceive a child with her own egg through assisted reproduction, carry the child, and then relinquish parental rights to intended parents under a compensated arrangement.
Critics have seized on that point, arguing that genetic surrogacy is fundamentally different from the more familiar gestational model, where the woman carrying the pregnancy has no genetic tie to the child. SB 250 expressly authorizes agreements in which a woman relinquishes parental rights to a child conceived through assisted reproduction and creates a framework for courts to validate these arrangements, including after conception has already occurred. The bill also states that a child born through gestational or genetic surrogacy has equal legal protections regardless of the circumstances of birth.
Once money changes hands for a woman to conceive and surrender her own genetic child, the state is no longer merely regulating family formation. It is creating a market framework around motherhood itself.
That is why the fight over SB 250 has become so intense. It is a moral and legal argument about whether the law should treat children as the subject of contracts and whether the biological bond between mother and child can be commercialized under a softer label.
Delaware may call this “genetic surrogacy,” but changing the terminology does not change the reality. When a woman is paid to conceive and surrender her own biological child, the law is edging into territory that treats children less like gifts and more like goods.